Cover Image

Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies

Bacterial cytosine deaminase (CD) converts the non-toxic prodrug 5-fluorocytosine (5-FC) into 5-fluorouracil (5-FU), which is toxic for mammalian cells. Therefore, the CD gene is used in cancer gene therapy to achieve high local concentration of a toxic metabolite without significant systemic toxici...

Full description

Saved in:
Bibliographic Details
Main Authors: Haack, Karin (Author) , Moebius, Ulrich (Author) , Knebel Doeberitz, Magnus von (Author) , Herfarth, Christian (Author) , Schackert, Hans K. (Author) , Gebert, Johannes (Author)
Format: Article (Journal)
Language:English
Published: 1997
In: Human gene therapy
Year: 1997, Volume: 8, Issue: 11, Pages: 1395-1401
ISSN:1557-7422
DOI:10.1089/hum.1997.8.11-1395
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1089/hum.1997.8.11-1395
Verlag, lizenzpflichtig, Volltext: https://www.liebertpub.com/doi/10.1089/hum.1997.8.11-1395
Get full text
Author Notes:K. Haack, U. Moebius, M.V. Knebel Doeberitz, Ch. Herfarth, H.-K. Schackert, J.F. Gebert

MARC

LEADER 00000naa a2200000 c 4500
001 1933691999
003 DE-627
005 20250821095718.0
007 cr uuu---uuuuu
008 250821s1997 xx |||||o 00| ||eng c
024 7 |a 10.1089/hum.1997.8.11-1395  |2 doi 
035 |a (DE-627)1933691999 
035 |a (DE-599)KXP1933691999 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Haack, Karin  |e VerfasserIn  |0 (DE-588)1374427977  |0 (DE-627)1933692545  |4 aut 
245 1 0 |a Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies  |c K. Haack, U. Moebius, M.V. Knebel Doeberitz, Ch. Herfarth, H.-K. Schackert, J.F. Gebert 
264 1 |c 1997 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Elektronische Reproduktion der Druck-Ausgabe 20. März 2008 
500 |a Gesehen am 21.08.2025 
520 |a Bacterial cytosine deaminase (CD) converts the non-toxic prodrug 5-fluorocytosine (5-FC) into 5-fluorouracil (5-FU), which is toxic for mammalian cells. Therefore, the CD gene is used in cancer gene therapy to achieve high local concentration of a toxic metabolite without significant systemic toxicity. To allow the detection of CD expression at the protein level, we raised both polyclonal rabbit antisera and a monoclonal antibody (mAb) against a histidine-tagged CD fusion protein. The specificity of the polyclonal antisera and the mAb was confirmed by immunohistochemistry, immunoblot analysis, and immunoprecipitation using CD-expressing tumor cell lines. Furthermore, the antibodies can be used for ELISA assays and flow cytometry. Finally, the CD protein could be demonstrated in frozen tissue sections of CD-modified tumors in a rat tumor model using the anti-CD serum. With these antibodies, CD expression can now be monitored throughout in vitro and in vivo gene transfer studies, including clinical protocols relying on the CD suicide gene strategy. 
700 1 |a Moebius, Ulrich  |d 1958-  |e VerfasserIn  |0 (DE-588)1074037340  |0 (DE-627)830180060  |0 (DE-576)43554277X  |4 aut 
700 1 |a Knebel Doeberitz, Magnus von  |e VerfasserIn  |0 (DE-588)1022165291  |0 (DE-627)71693289X  |0 (DE-576)364934239  |4 aut 
700 1 |a Herfarth, Christian  |d 1933-2014  |e VerfasserIn  |0 (DE-588)120706385  |0 (DE-627)080841562  |0 (DE-576)213333414  |4 aut 
700 1 |a Schackert, Hans K.  |e VerfasserIn  |0 (DE-588)1105593142  |0 (DE-627)862721326  |0 (DE-576)169890007  |4 aut 
700 1 |a Gebert, Johannes  |e VerfasserIn  |0 (DE-588)1033923567  |0 (DE-627)743674731  |0 (DE-576)381600688  |4 aut 
773 0 8 |i Enthalten in  |t Human gene therapy  |d New York, NY : Liebert, 1990  |g 8(1997), 11, Seite 1395-1401  |h Online-Ressource  |w (DE-627)306585332  |w (DE-600)1498064-2  |w (DE-576)094476950  |x 1557-7422  |7 nnas  |a Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies 
773 1 8 |g volume:8  |g year:1997  |g number:11  |g pages:1395-1401  |g extent:7  |a Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies 
856 4 0 |u https://doi.org/10.1089/hum.1997.8.11-1395  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.liebertpub.com/doi/10.1089/hum.1997.8.11-1395  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250821 
993 |a Article 
994 |a 1997 
998 |g 1033923567  |a Gebert, Johannes  |m 1033923567:Gebert, Johannes  |d 910000  |d 912000  |e 910000PG1033923567  |e 912000PG1033923567  |k 0/910000/  |k 1/910000/912000/  |p 6  |y j 
998 |g 1105593142  |a Schackert, Hans K.  |m 1105593142:Schackert, Hans K.  |p 5 
998 |g 120706385  |a Herfarth, Christian  |m 120706385:Herfarth, Christian  |d 910000  |d 910200  |e 910000PH120706385  |e 910200PH120706385  |k 0/910000/  |k 1/910000/910200/  |p 4 
998 |g 1022165291  |a Knebel Doeberitz, Magnus von  |m 1022165291:Knebel Doeberitz, Magnus von  |d 910000  |d 912000  |e 910000PK1022165291  |e 912000PK1022165291  |k 0/910000/  |k 1/910000/912000/  |p 3 
998 |g 1074037340  |a Moebius, Ulrich  |m 1074037340:Moebius, Ulrich  |d 910000  |d 911600  |e 910000PM1074037340  |e 911600PM1074037340  |k 0/910000/  |k 1/910000/911600/  |p 2 
998 |g 1374427977  |a Haack, Karin  |m 1374427977:Haack, Karin  |d 50000  |e 50000PH1374427977  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1933691999  |e 4759433260 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["K. Haack, U. Moebius, M.V. Knebel Doeberitz, Ch. Herfarth, H.-K. Schackert, J.F. Gebert"]},"origin":[{"dateIssuedDisp":"1997","dateIssuedKey":"1997"}],"id":{"eki":["1933691999"],"doi":["10.1089/hum.1997.8.11-1395"]},"physDesc":[{"extent":"7 S."}],"relHost":[{"origin":[{"publisherPlace":"New York, NY","dateIssuedKey":"1990","publisher":"Liebert","dateIssuedDisp":"1990-"}],"title":[{"title_sort":"Human gene therapy","title":"Human gene therapy"}],"id":{"eki":["306585332"],"zdb":["1498064-2"],"issn":["1557-7422"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Detection of cytosine deaminase in genetically modified tumor cells by specific antibodiesHuman gene therapy","language":["eng"],"recId":"306585332","pubHistory":["1.1990 -"],"part":{"issue":"11","pages":"1395-1401","year":"1997","extent":"7","volume":"8","text":"8(1997), 11, Seite 1395-1401"}}],"person":[{"role":"aut","display":"Haack, Karin","roleDisplay":"VerfasserIn","given":"Karin","family":"Haack"},{"display":"Moebius, Ulrich","roleDisplay":"VerfasserIn","role":"aut","family":"Moebius","given":"Ulrich"},{"role":"aut","display":"Knebel Doeberitz, Magnus von","roleDisplay":"VerfasserIn","given":"Magnus von","family":"Knebel Doeberitz"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Herfarth, Christian","given":"Christian","family":"Herfarth"},{"given":"Hans K.","family":"Schackert","role":"aut","roleDisplay":"VerfasserIn","display":"Schackert, Hans K."},{"role":"aut","display":"Gebert, Johannes","roleDisplay":"VerfasserIn","given":"Johannes","family":"Gebert"}],"title":[{"title_sort":"Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies","title":"Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies"}],"note":["Elektronische Reproduktion der Druck-Ausgabe 20. März 2008","Gesehen am 21.08.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1933691999"} 
SRT |a HAACKKARINDETECTIONO1997 

Similar Items